eFT508

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Microsatellite Stable Relapsed or Refractory Colorectal Cancer

Drug Information

Target Indication

Microsatellite Stable Relapsed or Refractory Colorectal Cancer

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

EFTR

eFFECTOR Therapeutics, Inc.

Related Pipeline

Non-small Cell Lung Cancer

Solid Tumors

Solid Tumor, Adult

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts